# AMLODIPINE BESYLATE
> **ANDA219686** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2026-01-22
## Drug
- **FDA Application Number:** ANDA219686
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE BESYLATE
- **Generic name:** Amlodipine Besylate
- **Active ingredients:** AMLODIPINE BESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **First approval:** 2026-01-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219686)
---
*AI Analytics · CC0 1.0*